Download the Article

Thank you for your interest in the article:
Understanding Regulation and Validation Processes for Biomarkers

Read Now >

Learn More About Medpace’s Biomarker Capabilities

Medpace’s central laboratory biomarker team is led by PhD level scientists who oversee the robust pipeline of new biomarker validations. The central lab validates all assays based on guidelines from the Clinical and Laboratory Standards Institute (CLSI) and in accordance with CAP and CLIA regulations. Medpace central laboratories validate new biomarkers quickly in an industry-leading  10-12 weeks.

Medpace’s central lab and bioanalytical lab expertise in biomarker development and validation are enhanced by the experience and capabilities of our network of reference and strategic laboratory partners as a seamless service to our clients.

Our lab services include:

  • Anatomical Pathology
  • Companion Diagnostics
  • Cytogenetics
  • DNA/RNA Services
  • Genomics Analysis
  • FISH
  • Flow Cytometry
  • Fluorescence Microscopy
  • Functional and Receptor Assays
  • IHC Testing
  • Large and Small Molecule Expertise
  • Ligand Binding Assays
  • Mass Spectrometry: LC/MS/MS, GC/MS
  • Microbiology
  • Multiplex Platforms
  • PK/PD Testing
  • Proteomics
  • Virology
  • Learn more about our capabilities or contact us to connect with our internal experts.

    You may also be interested in the Article:
    Flow Cytometry: Its Role in Clinical Trial Biomarkers